Search Results 781-790 of 16518 for Acrivastine
Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The ...
Cixutumumab may kill cancer cells by blocking the action of a protein needed for cancer cell growth. Giving paclitaxel with or without cixutumumab may kill more ...
The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by collecting stool and ...
About this study. The purpose of this study is to assess the combination of INCMGA00012 with radiation therapy (RT) and bevacizumab with or without ...
The primary purpose of this study is to create a prospective registry of patients with pouch-related conditions to allow for longitudinal assessment of ...
About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...
Rochester, Minn. The purpose of this study is to evaluate the effects of improving glycemic control, and/or reducing glycemic variability on gastric emptying, ...
Her F, Kubrova E, ElSaban M, Dombovy-Johnson M, Mostert K, D'Souza R. Complex Regional Pain Syndrome: Updates and Current Evidence Current Physical Medicine and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
There is currently no efficacious treatment available for PF-ILD. Based on its efficacy and safety in Idiopatic Pulmonary Fibrosis (IPF), it is anticipated that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!